Simplify Asset Management’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Sell
30,725
-13,168
-30% -$162K 0.01% 112
2026
Q1
$487K Buy
+43,893
New +$393K 0.01% 106

Other funds holding IMUX

Simplify Asset Management's IMUX Position: Q2 2026 in Review

Simplify Asset Management reduced its Immunic (IMUX) stake by 30% in Q2 2026, selling an estimated $162K and leaving 30,725 shares worth $472K. The position accounts for 0.01% of the portfolio, ranked #112.

Simplify Asset Management first reported a position in IMUX in Q1 2026 and has held it in 2 quarters since. The position peaked at $487K in Q1 2026. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Simplify Asset Management held 30,725 shares of Immunic worth $472K as of Q2 2026.
  • Simplify Asset Management sold 13,168 Immunic shares in Q2 2026, an estimated $162K.
  • Immunic made up 0.01% of Simplify Asset Management's portfolio in Q2 2026, its #112 holding.
  • Simplify Asset Management first reported a position in Immunic in Q1 2026 and has held it in 2 quarters since.
  • Simplify Asset Management's Immunic position peaked at $487K in Q1 2026.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.